Publication | Closed Access

Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm

Chronic PhaseThrombosisVascular DiseaseCardiovascular DiseaseMedicinePharmacologyCerebral VasospasmVascular BiologyBrain InjuryNeurologyNeuroscienceNeurovascular DiseaseCerebral Blood FlowArterial NarrowingStrokeAtherosclerosisIschemic SyndromeCerebral Vascular Regulation